Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors

Journal of Clinical Oncology

Volumn 27, Issue 13, 2009, Pages 2129-2136

  Honecker, Friedemann ^a   Wermann, Hendrik ^a   Mayer, Frank ^a   Gillis, Ad J M ^a   Stoop, Hans ^a   Van Gurp, Ruud J L M ^a   Oechsle, Karin ^a   Steyerberg, Ewout ^a   Hartmann, Jörg Th ^a   Dinjens, Winand N M ^a   Oosterhuis, J Wolter ^a   Bokemeyer, Carsten ^a   Looijenga, Leendert H J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CISPLATIN; K RAS PROTEIN; PROTEIN MLH1; PROTEIN MSH6; ADENOSINE TRIPHOSPHATASE; BRAF PROTEIN, HUMAN; DNA BINDING PROTEIN; KRAS PROTEIN, HUMAN; MLH1 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; PMS2 PROTEIN, HUMAN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; RAS PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; GENE LOCUS; GENE MUTATION; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METHYLATION; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; NON SEMINOMATOUS GERMINOMA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROMOTER REGION; SEMINOMA; TREATMENT FAILURE; WILD TYPE; ADOLESCENT; DRUG RESISTANCE; GENETICS; HETEROZYGOSITY LOSS; MIDDLE AGED; MUTATION; NEOPLASM; TESTIS TUMOR;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATASES; ADOLESCENT; ADULT; AGED; CISPLATIN; DNA MISMATCH REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTATION; NEOPLASMS, GERM CELL AND EMBRYONAL; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; TESTICULAR NEOPLASMS;

EID: 65549094095     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.18.8623     Document Type: Article

References (47)

1. Ulbright TM: Germ cell neoplasms of the testis. Am J Surg Pathol 17:1075-1091, 1993
2. Einhorn LH: Curing metastatic testicular cancer. Proc Natl Acad Sci U S A 99:4592-4595, 2002
3. Mayer F, Honecker F, Looijenga LH, et al: Towards understanding the biological basis of the response to cisplatin-based chemotherapy in germ cell tumors. Ann Oncol 9:825-832, 2003 (Pubitemid 36827197)
4. Bartkova J, Rajpert-De Meyts E, Skakkebaek NE, et al: DNA damage response in human testes and testicular germ cell tumours: Biology and implications for therapy. Int J Androl 30:282-291, 2007; discussion 291 (Pubitemid 47254412)
5. Olasz J, Mándoky L, Géczi L, et al: Influence of hMLH1 methylation, mismatch repair deficiency and microsatellite instability on chemoresistance of testicular germ-cell tumors. Anticancer Res 25:4319-4324, 2005 (Pubitemid 41665223)
6. Mayer F, Gillis AJ, Dinjens W, et al: Microsatellite instability of germ cell tumors is associated with resistance to systemic treatment. Cancer Res 62:2758-2760, 2002 (Pubitemid 34525757)
7. Velasco A, Corvalan A, Wistuba II, et al: Mismatch repair expression in testicular cancer predicts recurrence and survival. Int J Cancer 122:1774-1777, 2008
8. Velasco A, Riquelme E, Schultz M, et al: Microsatellite instability and loss of heterozygosity have distinct prognostic value for testicular germ cell tumor recurrence. Cancer Biol Ther 3:1152-1158, 2004 (Pubitemid 41350999)
9. Deng G, Bell I, Crawley S, Gum J, et al: BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer. Clin Cancer Res 10:191-195, 2004 (Pubitemid 38114179)
10. Rajagopalan H, Bardelli A, Lengauer C, et al: Tumorigenesis: RAF/RAS oncogenes and mismatchrepair status. Nature 418:934, 2002 (Pubitemid 34976022)
11. Yuen ST, Davies H, Chan TL, et al: Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res 62:6451-6455, 2002 (Pubitemid 35364105)
12. Nagasaka T, Sasamoto H, Notohara K, et al: Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation. J Clin Oncol 22:4584-4594, 2004 (Pubitemid 41185126)
13. Sommerer F, Hengge UR, Markwarth A, et al: Mutations of BRAF and RAS are rare events in germ cell tumours. Int J Cancer 113:329-335, 2005 (Pubitemid 39628326)
14. McIntyre A, Summersgill B, Spendlove HE, et al: Activating mutations and/or expression levels of tyrosine kinase receptors GRB7, RAS, and BRAF in testicular germ cell tumors. Neoplasia 7:1047-1052, 2005
15. Davies H, Bignell GR, Cox C, et al: Mutations of the BRAF gene in human cancer. Nature 417:949-954, 2002 (Pubitemid 34716871)
16. Roelofs H, Mostert MC, Pompe K, et al: Restricted 12p-amplification and RAS mutation in human germ cell tumors of the adult testis. Am J Pathol 157:1155-1166, 2000 (Pubitemid 30757938)
17. Mayer F, Stoop H, Scheffer GL, et al: Molecular determinants of treatment response in human germ cell tumors. Clin Cancer Res 9:767-773, 2003 (Pubitemid 36182613)
18. Looijenga LH, Gillis AJ, Verkerk AJ, et al: Heterogeneous X inactivation in trophoblastic cells of human full-term female placentas. Am J Hum Genet 64:1445-1452, 1999
19. Boland CR, Thibodeau SN, Hamilton SR, et al: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248-5257, 1998
20. de Jong J, Stoop H, Gillis AJ, et al: Further characterization of the first seminoma cell line TCam-2. Genes Chromosomes Cancer 47:185-196, 2008 (Pubitemid 351162849)
21. Chen CY, Shiesh SC, Wu SJ: Rapid detection of K-ras mutations in bile by peptide nucleic acidmediated PCR clamping and melting curve analysis: Comparison with restriction fragment length polymorphism analysis. Clin Chem 50:481-489, 2004
22. Oosterhuis J, Looijenga L: Testicular germcell tumours in a broader perspective. Nat Rev Cancer 5:210-222, 2005 (Pubitemid 40314952)
23. Houldsworth J, Korkola JE, Bosl GJ, et al: Biology and genetics of adult male germ cell tumors. J Clin Oncol 24:5512-5518, 2006 (Pubitemid 46631331)
24. Garner MJ, Turner MC, Ghadirian P, et al: Epidemiology of testicular cancer: An overview. Int J Cancer 116:331-339, 2005
25. Velasco A, Riquelme E, Schultz M, et al: Mismatch repair gene expression and genetic instability in testicular germ cell tumor. Cancer Biol Ther 3:977-982, 2004 (Pubitemid 41351023)
26. Kersemaekers AMF, Mayer F, Molier M, et al: Role of P53 andMDM2in treatment response of human germ cell tumors. J Clin Oncol 20:1551-1561, 2002 (Pubitemid 34260535)
27. Hartmann JT, Einhorn L, Nichols CR, et al: Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: Results of an international multicenter analysis. J Clin Oncol 19:1641-1648, 2001 (Pubitemid 32230863)
28. Oldenburg J, Martin JM, Fossa SD: Late relapses of germ cell malignancies: Incidence, management, and prognosis. J Clin Oncol 24:5503-5511, 2006 (Pubitemid 46631330)
29. Bokemeyer C, Nichols CR, Droz JP, et al: Extragonadal germ cell tumors of the mediastinum and retroperitoneum: Results from an international analysis. J Clin Oncol 20:1864-1873, 2002
30. Bouvier R, et al: Expression of hMLH1 and hMSH2 and assessment of microsatellite instability in testicular and mediastinal germ cell tumours. Mol Hum Reprod 7:1099-1105, 2001 (Pubitemid 33150204)
31. Jiricny J: The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol 7:335-346, 2006
32. Mueller S, Schittenhelm M, Honecker F, et al: Cell-cycle progression and response of germ cell tumors to cisplatin in vitro. Int J Oncol 29:471-479, 2006
33. Kumar R, Angelini S, Czene K, et al: BRAF mutations in metastatic melanoma: A possible asssociation with clinical outcome. Clin Cancer Res 9:3362-3368, 2003 (Pubitemid 37082731)
34. Miyashita K, Fujii K, Yamada Y, et al: Frequent microsatellite instability in non-Hodgkin lymphomas irresponsive to chemotherapy. Leuk Res 32:1183-1195, 2008
35. Wild PJ, Reichle A, Andreesen R, et al: Microsatellite instability predicts poor short-term survival in patients with advanced breast cancer after high-dose chemotherapy and autologous stem-cell transplantation. Clin Cancer Res 10:556-564, 2004 (Pubitemid 38173994)
36. Anthoney DA, McIlwrath AJ, Gallagher WM, et al: Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. Cancer Res 56:1374-1381, 1996 (Pubitemid 26080982)
37. Valentini AM, Armentano R, Pirrelli M, et al: Chemotherapeutic agents for colorectal cancer with a defective mismatch repair system: The state of the art. Cancer Treat Rev 32:607-618, 2006 (Pubitemid 44649135)
38. Kollmannsberger C, Nichols C, Bokemeyer C: Recent advances in management of patients with platinum-refractory testicular germ cell tumors. Cancer 106:1217-1226, 2006 (Pubitemid 43363897)
39. Hiles JJ, Kolesar JM: Role of sunitinib and sorafenib in the treatment of metastatic renal cell carcinoma. Am J Health Syst Pharm 65:123-131, 2008
40. Strumberg D, Seeber S: Raf kinase inhibitors in oncology. Onkologie 28:101-107, 2005
41. Allen LF, Sebolt-Leopold J, Meyer MB: CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK). Semin Oncol 30:105-116, 2003 (suppl 16)
42. Rinehart J, Adjei AA, Lorusso PM, et al: Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer. J Clin Oncol 22:4456-4462, 2004 (Pubitemid 41185111)
43. Adjei AA, Cohen RB, Franklin W, et al: Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers. J Clin Oncol 26:2139-2146, 2008
44. Shinozaki M, O'Day SJ, Kitago M, et al: Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapy. Clin Cancer Res 13:2068-2074, 2007 (Pubitemid 46649874)
45. Daniotti M, Vallacchi V, Rivoltini L, et al: Detection of mutated BRAFV600E variant in circulating DNA of stage III-IV melanoma patients. Int J Cancer 120:2439-2444, 2007 (Pubitemid 46642132)
46. Kölble K, Ullrich OM, Pidde H, et al: Microsatellite alterations in serum DNA of patients with colorectal cancer. Lab Invest 79:1145-1150, 1999 (Pubitemid 29444546)
47. Schwarzenbach H, Müller V, Stahmann N, et al: Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer. Ann N Y Acad Sci 1022:25-32, 2004 (Pubitemid 38951577)